These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27608143)

  • 1. Anatomical, functional and quality-of-life results for mastoid and epitympanic obliteration with bioactive glass s53p4: a prospective clinical study.
    Bernardeschi D; Pyatigorskaya N; Russo FY; De Seta D; Corallo G; Ferrary E; Nguyen Y; Sterkers O
    Clin Otolaryngol; 2017 Apr; 42(2):387-396. PubMed ID: 27608143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III tympanoplasty with titanium total ossicular replacement prosthesis: anatomic and functional results.
    Iñiguez-Cuadra R; Alobid I; Borés-Domenech A; Menéndez-Colino LM; Caballero-Borrego M; Bernal-Sprekelsen M
    Otol Neurotol; 2010 Apr; 31(3):409-14. PubMed ID: 20042992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study.
    Bernardeschi D; Nguyen Y; Russo FY; Mosnier I; Ferrary E; Sterkers O
    Biomed Res Int; 2015; 2015():242319. PubMed ID: 26504792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
    Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
    Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket.
    Lee WS; Choi JY; Song MH; Son EJ; Jung SH; Kim SH
    Otol Neurotol; 2005 Nov; 26(6):1107-11. PubMed ID: 16272924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired middle ear cholesteatoma in children with cleft palate: experience from 18 surgical cases.
    Vincenti V; Marra F; Bertoldi B; Tonni D; Saccardi MS; Bacciu S; Pasanisi E
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):918-22. PubMed ID: 24690221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of revision mastoidectomy.
    Berçin S; Kutluhan A; Bozdemir K; Yalçiner G; Sari N; Karamese O
    Acta Otolaryngol; 2009 Feb; 129(2):138-41. PubMed ID: 18607914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bony obliteration tympanoplasty in cholesteatoma: safety, hygiene and hearing outcome: allograft versus autograft tympanic membrane reconstruction.
    van Waegeningh HF; van Dinther JJS; Vanspauwen R; Zarowski A; Offeciers E
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1805-1813. PubMed ID: 32761272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up.
    Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ
    Otol Neurotol; 2022 Dec; 43(10):1181-1188. PubMed ID: 36099589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastoidectomy and mastoid obliteration with autologous bone graft: a quality of life study.
    Kurien G; Greeff K; Gomaa N; Ho A
    J Otolaryngol Head Neck Surg; 2013 Sep; 42(1):49. PubMed ID: 24330542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canal-wall up cholesteatoma surgery with mastoid obliteration leads to lower rates of disease recurrence without affecting hearing outcomes.
    Erfurt C; Westerhout SF; Straatman LV; Smit AL; Stokroos RJ; Thomeer HGXM
    Front Surg; 2024; 11():1381481. PubMed ID: 38650663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery.
    de Veij Mestdagh PD; Colnot DR; Borggreven PA; Orelio CC; Quak JJ
    Acta Otolaryngol; 2017 Jul; 137(7):690-694. PubMed ID: 28125327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of bone pate and bioactive glass granules for mastoid obliteration in cholesteatoma surgery].
    Gerlinger I; Szabó É; Szanyi I; Rostás T; Pap I; Révész P; Kopjár E
    Orv Hetil; 2022 May; 163(21):838-845. PubMed ID: 35598213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.